Perspective Therapeutics (CATX) Notes Payables (2023 - 2025)
Historic Notes Payables for Perspective Therapeutics (CATX) over the last 3 years, with Q3 2025 value amounting to $55000.0.
- Perspective Therapeutics' Notes Payables rose 784.31% to $55000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $55000.0, marking a year-over-year increase of 784.31%. This contributed to the annual value of $52000.0 for FY2024, which is 612.24% up from last year.
- Latest data reveals that Perspective Therapeutics reported Notes Payables of $55000.0 as of Q3 2025, which was up 784.31% from $54000.0 recorded in Q2 2025.
- In the past 5 years, Perspective Therapeutics' Notes Payables ranged from a high of $1.8 million in Q1 2023 and a low of $49000.0 during Q4 2023
- Over the past 3 years, Perspective Therapeutics' median Notes Payables value was $54000.0 (recorded in 2024), while the average stood at $520000.0.
- Its Notes Payables has fluctuated over the past 5 years, first plummeted by 9721.14% in 2024, then soared by 784.31% in 2025.
- Quarter analysis of 3 years shows Perspective Therapeutics' Notes Payables stood at $49000.0 in 2023, then increased by 6.12% to $52000.0 in 2024, then increased by 5.77% to $55000.0 in 2025.
- Its last three reported values are $55000.0 in Q3 2025, $54000.0 for Q2 2025, and $53000.0 during Q1 2025.